Drugs / Phexxi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05753813 | Dec 2023 → Oct 2026 expected | bacterial vaginosis, vulvovaginal candidiasis | Queen's Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phexxi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05753813 ↗ |
| Route | Other | “intravaginal gel twice weekly for 4 weeks.” NCT05753813 ↗ |